Engineering
the Future of
Phospholipid
Platform
DKD Phoxis builds a phospholipid-based platform designed for biomimetic interfaces—supporting delivery, barrier function, and tissue-level responses across human-relevant contexts.
Our work focuses on translational deployment where performance is shaped by membrane interaction, microenvironment complexity, and real-world constraints.
PLATFORM NAPSHOT
Phospholipid Platform
Solvent-free, egg-derived phospholipid system engineered for biological membrane compatibility and translational adaptability.
Biological Interface
Functions at the membrane level — bridging active compounds and complex human tissue microenvironments.
Translational by Design
Structured for real-world biomedical deployment across regenerative, mucosal, and orphan-focused contexts.
The Biological Translation Gap
Complex Biological Interfaces
Therapeutic strategies often focus on isolated molecular activity, while biological systems operate within dynamic, membrane-mediated environments that influence absorption, stability, and tissue response.
Model-to-Human Discrepancies
Preclinical performance does not consistently translate into clinically meaningful outcomes, particularly in fragile or heterogeneous tissue conditions.
Deployment Constraints
Even promising therapeutic approaches remain limited by cost, infrastructure requirements, and regulatory complexity, restricting real-world accessibility.
Platform Architecture
A structural response to biological complexity — built around membrane-level compatibility, functional adaptability, and translational deployment.
Biomimetic membrane compatibility
Phospholipid structures designed to operate at biological boundaries — where absorption, barrier behavior, and tissue interaction are shaped.
Formulation as a controlled environment
A platform approach that supports delivery, barrier modulation, and microenvironment stability without relying on a single indication or mechanism.
Adaptable formats for real-world deployment
Structured for translation across contexts — enabling iteration on format, dosing logic, and manufacturability as evidence evolves.
Translational
Mindset
We approach development not as product iteration, but as system alignment — integrating biological constraints, regulatory pathways, and manufacturability from the earliest stage.
Biology First
Platform decisions are shaped by tissue-level interaction and membrane behavior, not only molecular activity.
Regulatory Awareness
Structural design considers classification, evidence generation, and pathway feasibility early in development.
Deployment Reality
Real-world usability, cost structure, and accessibility are engineered into the platform, not treated as secondary concerns.
Scalable Adaptation
Format flexibility allows iteration across indications while preserving structural integrity.
Strategic Pipeline
Platform-driven pathways structured by biological interface context — not by a single product.
Regenerative Interfaces
Biomimetic support where tissue integrity, barrier restoration, and microenvironment stability shape outcomes.
Explore Translation →Mucosal Contexts
Targeting delivery and barrier dynamics within sensitive mucosal environments where conventional formats underperform.
Explore Platform →Barrier Modulation
Platform configurations designed to interact with membrane behavior and surface physiology under real-world constraints.
View Evidence →Orphan-Focused Exploration
Structured pathways for rare or high-need contexts where translational feasibility and deployment matter as much as novelty.
Partner With Us →
Evidence &
Validation Framework
Platform development at DKD Phoxis is guided by intellectual property, structured validation logic, and early-stage regulatory awareness. Evidence generation is treated as an architectural process — not a post-development formality.
Explore Scientific Positioning →Intellectual Property Foundation
Structural processes underlying the phospholipid platform are protected and form the basis for translational iteration.
Iterative Validation Logic
Development follows interface-level biological reasoning, emphasizing functional coherence across contexts rather than single-indication optimization.
Regulatory-Conscious Structuring
Classification pathways and deployment feasibility are considered early to support translational scalability.
Strategic Collaboration
DKD Phoxis engages with scientific, translational, and clinical partners exploring membrane-level platforms in high-need biological contexts. We welcome dialogue grounded in structured inquiry, regulatory awareness, and long-term deployment feasibility.